Analysis of Immunochemical Parameters in Vertebrogenic Pain Syndrome

Article Sidebar

pdf (Русский) html (Русский) html
Published: Jul 12, 2018
DOI: https://doi.org/10.18097/BMCRM00039
Keywords:
vertebrogenic pain syndrome natural antibodies β-endorphin orphanin FQ serotonin dopamine

Main Article Content

A.I. Levashova
Institute of Physiologically Active Compounds of RAS, 1 Severny proezd, Moscow region, Chernogolovka, 142432 Russia
M.A. Myagkova
Institute of Physiologically Active Compounds of RAS, 1 Severny proezd, Moscow region, Chernogolovka, 142432 Russia

Abstract

The immune system can react to pain by synthesis of the natural antibodies to pain-regulating mediators which affec t the nervous system. In this study, the analysis of content antibodies to opioid peptides (β-endorphin and orphanin FQ) and biogenic amines (serotonin and dopamine) in vertebrogenic pain syndrome (PS) was carries out in serum of PS patients. It has been found that this PS is accompanied by an increase in the production of antibodies to the neurotransmitters studied, and the immune response to opioid peptides is more profound than to biogenic amines. The antibodies levels were higher in female patients than in males (especially for orphanin FQ). These data indirectly correlate with the PS intensity and the dynamics of its regression, evaluated using a visual analogue scale (VAS). Thus, the pain intensity measured by VAS in women was higher, in compare with men and the dynamics of decrease was lower. In addition, it was found that during the significant decrease of the pain intensity, there was no significant decrease in antibody levels to antinociceptive mediators. Apparently, this observation indicates the antibodies to antinociceptive mediators can effect the mechanisms of transition from acute to chronic pain and in maintenance of chronic pain.

Article Details

How to Cite
Levashova, A., & Myagkova, M. (2018). Analysis of Immunochemical Parameters in Vertebrogenic Pain Syndrome. Biomedical Chemistry: Research and Methods, 1(3), e00039. https://doi.org/10.18097/BMCRM00039
Issue
Vol. 1 No. 3 (2018)
Section
EXPERIMENTAL RESEARCH

References

  1. Pavlenko, S.S. (2007) Boli v nizhnej chasti spiny (ehpidemiologiya, kliniko-diagnosticheskaya klassifikaciya, sovremennye napravleniya v diagnostike, lechenii I standartizacii medicinskoj pomoshchi): rukovodstvo. Novosibirsk: Sibmedizdat, NGMU, 172 p.
  2. Reshetniak, V.K., Kukushkin, M.L. (2015) Modern understanding of the physiological and pathological pain. Clinical Pathophysiology, 1, 1-17.
  3. Jensen, I.B., Bodin, L., Ljungqvist, T., Gunnar Bergstrom, K., Nygren, A. (2000) Assessing the needs of patients in pain: a matter of opinion? Spine, 25 (21), 2816–2823.
  4. Golubev, V.L, Vein, A.M., Danilov, A.B. (2005) Gender and pain. Zh Nevrol Psikhiatr Im S.S. Korsakova, 10, 72–74.
  5. Kravchenko, L.M. (2011) Gender variations in German-speaking patients’ Description of pain. Vestn. Volgogr. State Univers. Ser. 2, Linguistic, 2 (14), 91-95.
  6. Williamson, A., Hoggart, B. (2005) Pain: a review of three commonly used pain rating scales. J. Clin. Nurs, 14 (7), 798–804. DOI
  7. Ovsyannikov, V.G., Boychenko, A.E., Alekseev, V.V., Kapliev, A.V., Alekseeva, N.S., Kotieva, I.M., Shumarin, A.E. (2014) Antinociceptive system. Medical Herald of the South of Russia, 3. 46-54. (In Russ.). DOI
  8. Pan, H.L., Wu, Z.Z., Zhou, H.Y., Chen, S.R., Zhang, H.M., Li, D.P. (2008) Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther, 117(1), 141-161. DOI
  9. Degenhardt, B.F., Darmani, N.A., Johnson, J.C., Towns L.C., Rhodes, D.C.J., Trinh, C., McClanahan, B., DiMarzo, V. (2007) Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. J Am Osteopath Assoc, 107, 387-400.
  10. Barnes, T.A., Lambert, D.G. (2004) Editorial III: Nociceptin/orphanin FQ peptide-receptor system: are we any nearer the clinic? Br. J. Anaesth., 93, 626–628. DOI
  11. Chiou, L.C., Liao, Y.Y., Fan, P.C., Kuo, P.H., Wang, C.H., Riemer C., Prinssen, E.P. (2007) Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Current drug targets, 8(1), 117-135. DOI
  12. Voznesenskaya, Т.G. (2008) Chronic pain and depression. Pharmateka, 6, 10-15.
  13. Hernandez-Reif, M., Field, T, Krasnegor, J, Theakston, H. (2001) Lower back pain is reduced and range of motion increased after massage therapy. Int. J. Neurosci., 106(3-4), 131-145. DOI
  14. Poletaev, А.B. (2010) Physiological Immunology: Natural Autoantibodies and Nanomedicine Problems. Publisher. Miklosh, Moscow, 218 p.
  15. Polyvyanaya, O.Y., Levashova, A.I., Morozova, V.S., Petrochenko, S.N., Myagkova, M.A., Moseikin, I.A. (2015) Dynamics of pain tolerance thresholds and humoral immunity factors at dorsalgy. Vestnik Rossiiskoi akademii meditsinskikh nauk. 70(1), 118-124 (In Russ.). DOI
  16. Igonkina, S.I., Vetrile, L.A., Zaharova, I.A., Kukushkin, M.L. (2015) Antibodies to neuromediators at neuropathic pain. Neuroimmunologia. 12(1-2), 45-46.
  17. Myagkova, M.A., Lushnikova М.V., Polevaya, О.Yu. (1992) Immunoglobulins binding biogenic amines in patients with drug dependence. Immunology. 3, 45-47.